Toronto - Free Realtime Quote CAD
Aptose Biosciences Inc. (APS.TO)
2.2300
+0.0100
+(0.45%)
As of 1:01:55 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-35,977
-35,977
-44,590
-32,322
-43,304
Investing Cash Flow
18
18
9,960
30,066
-35,208
Financing Cash Flow
33,414
33,414
6,910
116
226
End Cash Position
6,707
6,707
9,252
36,970
39,114
Capital Expenditure
-5
-5
-29
-24
-212
Issuance of Capital Stock
23,407
23,407
6,881
101
36
Issuance of Debt
10,000
10,000
0
--
--
Repurchase of Capital Stock
-21
-21
--
--
--
Free Cash Flow
-35,982
-35,982
-44,619
-32,346
-43,516
12/31/2021 - 4/25/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BETR.CN BetterLife Pharma Inc.
0.0850
-10.53%
ONC.TO Oncolytics Biotech Inc.
0.7200
0.00%
KNE.V Kane Biotech Inc.
0.0750
-6.25%
MDNA.TO Medicenna Therapeutics Corp.
1.0700
+7.00%
BCT.TO BriaCell Therapeutics Corp.
4.4700
+1.59%
MBX.TO Microbix Biosystems Inc.
0.3550
+1.43%
ACTU Actuate Therapeutics, Inc. Common stock
10.16
+2.63%
PMN ProMIS Neurosciences, Inc.
0.4876
-2.48%
RNTX Rein Therapeutics Inc.
1.6700
-4.02%
RNXT RenovoRx, Inc.
1.0769
+3.55%